SB4 in the Era of Biosimilars: Clinical Data and Real World Experience
A biosimilar is a biological medicinal product that is highly similar to an already authorized original biological medicinal product. The introduction of biosimilars may allow for a reduction in health care costs, due to discount pricing. Current clinical studies and real-world data suggest that the...
| Egile Nagusiak: | , |
|---|---|
| Formatua: | Journal article |
| Argitaratua: |
Greek Rheumatology Society and Professional Association of Rheumatologists
2019
|